Outlook Therapeutics, Inc.
NASDAQ:OTLK
1.47 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.854 | 0.584 | 0.641 | 1.068 | 0.772 | 0.772 | 0.772 | 0.772 | 2.902 | 0.303 | 0.303 | 0.303 | 0.495 | 0.495 | 0.995 | 0.995 | 0.495 | 1.295 | 0.495 | 2.935 |
| Cost of Revenue
| 0.029 | 0.028 | 0.028 | 0.011 | 0.011 | 0.011 | 0.011 | 0.051 | 0.051 | 0.051 | 0.051 | 0.051 | 0.048 | 0.082 | 0.012 | 0.008 | 0.008 | 0.004 | 0.006 | 0.007 | 0.004 | 0.006 | 0.006 | 0.007 | 0.006 | 0.005 | 0 | 0.002 | 0.004 | 0.004 | 0.013 | 0.004 | 0.012 | 0.004 | 0.013 | 0.013 | 0.01 | 0.01 | 0.006 |
| Gross Profit
| -0.029 | -0.028 | -0.028 | -0.011 | -0.011 | -0.011 | -0.011 | -0.051 | -0.051 | -0.051 | -0.051 | -0.051 | -0.048 | -0.082 | -0.012 | -0.008 | -0.008 | -0.004 | -0.006 | 5.846 | 0.58 | 0.635 | 1.062 | 0.765 | 0.766 | 0.767 | 0.771 | 2.9 | 0.299 | 0.299 | 0.29 | 0.491 | 0.483 | 0.991 | 0.982 | 0.482 | 1.285 | 0.485 | 2.929 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.999 | 0.993 | 0.991 | 0.994 | 0.991 | 0.992 | 0.993 | 0.999 | 0.999 | 0.986 | 0.986 | 0.956 | 0.992 | 0.976 | 0.996 | 0.987 | 0.973 | 0.993 | 0.979 | 0.998 |
| Reseach & Development Expenses
| 11.202 | 13.509 | 4.529 | 4.944 | 11.101 | 0.545 | 9.862 | 8.99 | 11.249 | 12.22 | 9.872 | 9.935 | 8.545 | 8.529 | 11.949 | 7.623 | 8.488 | 4.383 | 5.847 | 4.493 | 4.393 | 6.497 | 8.421 | 7.149 | 5.796 | 5.156 | 0.402 | 2.059 | 4.24 | 4.199 | 13.312 | 4.212 | 12.018 | 4.138 | 12.734 | 13.201 | 9.681 | 10.154 | 5.84 |
| General & Administrative Expenses
| 8.361 | 5.431 | 5.794 | 7.515 | 7.04 | 6.293 | 5.826 | 4.998 | 5.775 | 6.69 | 3.277 | 3.501 | 2.93 | 4.096 | 2.242 | 2.39 | 3.287 | 1.957 | 2.337 | 2.782 | 1.835 | 1.849 | 2.904 | 6.036 | 2.196 | 2.447 | 3.549 | 3.445 | 3.503 | 4.045 | 4.889 | 6.647 | 10.505 | -0.189 | 4.674 | 4.666 | 2.66 | 4.342 | 1.238 |
| Selling & Marketing Expenses
| -0.029 | -5,431,035.597 | 0 | 0 | 0 | 0 | 0 | 0 | -0.051 | -0.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.332 | 5.403 | 5.794 | 7.515 | 7.04 | 6.293 | 5.826 | 4.998 | 5.723 | 6.639 | 3.277 | 3.501 | 2.93 | 4.096 | 2.242 | 2.39 | 3.287 | 1.957 | 2.337 | 2.782 | 1.835 | 1.849 | 2.904 | 6.036 | 2.196 | 2.447 | 3.549 | 3.445 | 3.503 | 4.045 | 4.889 | 6.647 | 10.505 | -0.189 | 4.674 | 4.666 | 2.66 | 4.342 | 1.238 |
| Other Expenses
| 0 | -8.519 | -0.993 | -0.843 | -2.91 | -0.003 | 0 | 0 | -0.377 | -0.344 | -0.162 | 0 | 0 | 0 | 0 | 0 | 0 | 1.759 | 0.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 19.534 | 18.912 | 10.323 | 12.459 | 18.141 | 6.838 | 15.688 | 13.988 | 16.973 | 18.858 | 13.15 | 13.436 | 11.475 | 12.625 | 14.191 | 10.014 | 11.775 | 6.34 | 8.184 | 7.275 | 6.228 | 8.346 | 11.325 | 13.186 | 7.992 | 7.603 | 3.952 | 5.504 | 7.742 | 8.244 | 18.201 | 10.859 | 22.522 | 3.949 | 17.408 | 17.867 | 12.341 | 14.497 | 7.078 |
| Operating Income
| -19.563 | -18.94 | -10.323 | -12.459 | -18.141 | -6.838 | -15.688 | -13.988 | -17.024 | -18.91 | -13.15 | -13.436 | -11.475 | -12.625 | -14.191 | -10.014 | -11.879 | -6.764 | -8.184 | -12.692 | -5.644 | -7.705 | -10.257 | -12.414 | -7.22 | -6.831 | -3.18 | -2.602 | -7.439 | -7.941 | -17.898 | -10.364 | -22.027 | -2.954 | -16.413 | -17.372 | -11.046 | -14.002 | -4.143 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.168 | -9.667 | -12.02 | -9.608 | -16.082 | -9.354 | -8.85 | -4.119 | -0.897 | -24.54 | -26.195 | -59.042 | -20.941 | -44.51 | -2.969 | -16.497 | -35.102 | -8.53 | -28.292 | -1.412 |
| Total Other Income Expenses Net
| 63.972 | -95.346 | -0.855 | -0.532 | -2.534 | 0.186 | -2.974 | -0.357 | -0.516 | -0.793 | -1.313 | 0.031 | -0.722 | -0.479 | -0.265 | 0.091 | 5.593 | 1.064 | -8.419 | -0.038 | 0.426 | -2.539 | 0.515 | -0.284 | -1.212 | -0.709 | -1.891 | -3.279 | 2.005 | -0.207 | -1.3 | -0.232 | -0.299 | -0.538 | -0.399 | -0.679 | -0.555 | -0.706 | -0.358 |
| Income Before Tax
| 44.409 | -114.286 | -11.178 | -12.991 | -20.675 | -6.651 | -18.663 | -14.344 | -17.54 | -19.703 | -14.463 | -13.404 | -12.197 | -13.105 | -14.456 | -9.922 | -6.286 | -5.7 | -16.603 | -12.73 | -5.218 | -10.245 | -9.742 | -12.697 | -8.432 | -7.54 | -5.071 | -5.881 | -5.327 | -8.045 | -19.095 | -10.595 | -22.327 | -3.492 | -16.812 | -18.051 | -11.601 | -14.708 | -4.501 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.175 | -8.938 | -15.983 | -9.125 | -16.449 | -10.924 | -9.768 | -6.57 | -2.027 | -17.572 | -26.538 | -62.99 | -21.409 | -45.115 | -3.51 | -16.898 | -36.474 | -8.959 | -29.719 | -1.534 |
| Income Tax Expense
| 0 | 0.003 | -0.135 | 2,797.417 | -0.394 | 0.003 | 2.974 | 0.001 | -0 | 0.002 | 0.352 | -0.002 | -0.178 | 0.002 | 0.16 | -0.001 | -3.271 | 0.696 | 0.423 | -2.634 | -0.778 | 0.237 | 150,508 | -0.498 | 652,612 | 0.921 | -3.151 | 0.498 | 1.638 | 1.14 | 0.004 | -0.103 | 0.001 | 0.051 | 0.052 | 0.01 | 0.12 | -0.726 | 0.406 |
| Net Income
| 44.409 | -114.289 | -11.178 | -12.991 | -20.675 | -6.654 | -21.637 | -14.345 | -17.54 | -19.705 | -14.463 | -13.404 | -12.197 | -13.107 | -14.456 | -9.922 | -3.015 | -5.7 | -16.603 | -10.096 | -4.441 | -10.245 | -9.742 | -12.2 | -8.432 | -7.54 | -1.921 | -6.379 | -5.327 | -8.045 | -19.099 | -10.595 | -22.327 | -3.542 | -16.864 | -17.165 | -11.34 | -13.981 | -4.907 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.725 | -7.606 | -15.983 | -9.125 | -15.805 | -10.924 | -9.768 | -2.488 | -2.198 | -17.572 | -26.538 | -63.003 | -21.409 | -45.116 | -3.561 | -16.951 | -34.683 | -8.758 | -28.251 | -1.672 |
| EPS
| -0.97 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.9 | -1.35 | -1.59 | -1.8 | -1.54 | -1.59 | -1.45 | -1.74 | -2.37 | -2.19 | -0.66 | -2.38 | -11.11 | -7.06 | -3.86 | -17.78 | -19.79 | -24.79 | -39.06 | -46.88 | -12.29 | -41.28 | -34.87 | -54.26 | -131.73 | -74.21 | -189.85 | -24.86 | -179.51 | -182.71 | -120.71 | -148.82 | -52.23 |
| EPS Diluted
| -0.89 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.9 | -1.35 | -1.59 | -1.8 | -1.54 | -1.59 | -1.45 | -1.74 | -2.37 | -2.19 | -0.66 | -2.38 | -11.11 | -6.75 | -3.86 | -17.78 | -19.79 | -24.79 | -39.06 | -46.88 | -12.29 | -40.82 | -34.87 | -54.08 | -131.73 | -73.08 | -189.85 | -24.86 | -179.51 | -182.71 | -120.71 | -148.82 | -52.23 |
| EBITDA
| 44.438 | -18.912 | -10.295 | -12.98 | -20.664 | -6.827 | -15.677 | -13.932 | -16.973 | -18.858 | -14.06 | -13.085 | -11.891 | -12.772 | -14.215 | -9.823 | -5.72 | -4.828 | -15.83 | -11.631 | -3.303 | -8.374 | -7.798 | -10.768 | -6.462 | -5.913 | -3.677 | -2.75 | -3.017 | -6.225 | -18.038 | -9.76 | -21.429 | -2.356 | -15.819 | -16.41 | -10.625 | -13.783 | -3.921 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.091 | -8.24 | -12.02 | -8.837 | -15.014 | -8.289 | -7.902 | -3.243 | -0.666 | -22.323 | -23.951 | -56.833 | -19.721 | -43.3 | -2.368 | -15.9 | -33.158 | -8.205 | -27.85 | -1.336 |